Talk to Sam
+1 718 473 0872
Search inside this page
Free Market Research Guides to Download
» View Public Reports1 reports
... Take-over targets among large generics companies. Krka trades at a 4.7X 2012e ev/ebitda multiple, offering a wide discount to similarly sized regional and international peers. The portfolio weighted ...
» Purchase Premium Reports (From $ 305 - $ 305)2 reports
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
Reportlinker.com © Copyright 2013. All rights reserved.